Literature DB >> 21648058

Portland cement for bone tissue engineering: Effects of processing and metakaolin blends.

Daniel Gallego-Perez1, Natalia Higuita-Castro, Felipe García Quiroz, Olga M Posada, Luis E López, Alan S Litsky, Derek J Hansford.   

Abstract

The need for a suitable scaffolding material for load bearing bone tissue engineering still has yet to be met satisfactorily. In this study, Portland cement and Portland cement/metakaolin (MK) blends were processed to render them biologically and mechanically suitable for such application. Portland cement was mixed with MK at different ratios. The slurries were hydrated under atmospheric (noncarbonated samples) and high-CO₂ conditions (carbonated samples). The mechanical properties were characterized via compressive tests. The bioactivity was analyzed in a simulated body fluid solution. Scanning electron microscopy and energy dispersive spectroscopy were used to evaluate sample morphology and chemistry. The cytocompatibility (direct contact assay, MTT test, and alkaline phosphatase activity) was tested using human osteoblast-like cells. Cell responses were observed via conventional and electron microscopy. The results showed that the implementation of MK did not significantly influence the mechanical properties. All the samples evidenced bioactive behavior. Cell experiments confirmed a highly cytotoxic response to the noncarbonated specimens. The introduction of MK as well as the CO₂ pretreatment significantly improved the cytocompatibility of the specimens. These results show that properly processed Portland cement and Portland cement/MK blends could present suitable properties for the development of load-bearing scaffolding structures in bone tissue-engineering applications.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21648058     DOI: 10.1002/jbm.b.31853

Source DB:  PubMed          Journal:  J Biomed Mater Res B Appl Biomater        ISSN: 1552-4973            Impact factor:   3.368


  1 in total

1.  Early Intervention in Ischemic Tissue with Oxygen Nanocarriers Enables Successful Implementation of Restorative Cell Therapies.

Authors:  Ludmila Diaz-Starokozheva; Devleena Das; Xiangming Gu; Jordan T Moore; Luke R Lemmerman; Ian Valerio; Heather M Powell; Natalia Higuita-Castro; Michael R Go; Andre F Palmer; Daniel Gallego-Perez
Journal:  Cell Mol Bioeng       Date:  2020-05-29       Impact factor: 2.321

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.